Skip to main content

Table 14 Meta-analyses by type of cigarette smoked a

From: Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer

Type of cigarette smoked

Statisticb

All lung cancerc

Squamousd

Adenoe

Only filter vs. only plainf

n

42

13

10

 

F

0.67 (0.64-0.72)

0.58 (0.52-0.64)

0.88 (0.75-1.03)

 

R

0.69 (0.61-0.78)

0.52 (0.40-0.68)

0.84 (0.66-1.08)

 

H, PH

3.18, p < 0.001

4.73, p < 0.001

1.90, p < 0.05

Ever filter vs. only plaing

n

42

11

10

 

F

0.79 (0.75-0.83)

0.85 (0.79-0.91)

1.00 (0.89-1.12)

 

R

0.73 (0.65-0.82)

0.55 (0.41-0.74)

0.99 (0.84-1.16)

 

H, PH

3.60, p < 0.001

7.73, p < 0.001

1.35, NS

Only filter vs. ever plainh

n

42

13

10

 

F

0.67 (0.63-0.71)

0.87 (0.81-0.92)

1.05 (0.93-1.18)

 

R

0.70 (0.62-0.78)

0.69 (0.57-0.83)

0.98 (0.80-1.21)

 

H, PH

3.30, p < 0.001

3.15, p < 0.001

1.88, p < 0.05

Handrolled vs. manufacturedi

n

20

5

4

 

F

1.27 (1.16-1.40)

1.47 (1.24-1.76)

2.12 (1.53-2.96)

 

R

1.29 (1.12-1.49)

1.62 (1.18-2.21)

2.09 (0.83-5.25)

 

H, PH

1.81, p < 0.05

2.61, p < 0.05

6.54, p < 0.001

Mentholated vs. non-mentholated

n

6

1

1

 

F

0.99 (0.86-1.14)

1.04 (0.75-1.44)

0.96 (0.73-1.27)

 

R

0.98 (0.80-1.20)

1.04 (0.75-1.44)

0.96 (0.73-1.27)

 

H, PH

1.89, p < 0.1

NA

NA

  1. a Within each study, results for the relevant smoking product and smoking status are selected in the following preference order, within each sex, for:
  2. cigarette type – see notes f to i;
  3. unexposed group – see notes f to i;
  4. smoking product – any, cigarettes (ignoring other products), cigarettes only;
  5. smoking status – ever, current;
  6. lung cancer type – see notes c to e;
  7. race – all or nearest available, otherwise by race;
  8. follow-up period – longest available;
  9. overlapping studies – principal, subsidiary;
  10. age – whole study, widest available age group;
  11. Results are then selected for:
  12. sex – single sex results, combined sex results;
  13. adjustment for potential confounders – most available.
  14. b n = number of estimates combined, F = fixed-effect meta-analysis RR (95% CI), R = random-effects meta-analysis RR (95% CI), H = heterogeneity chisquared per degree of freedom, PH = probability value for heterogeneity expressed as p < 0.001, p < 0.05, p < 0.1 or NS (p ≥ 0.1), PB = probability value for between levels (see Methods) similarly expressed.
  15. c All or nearest available, must include at least squamous cell carcinoma and adenocarcinoma.
  16. d Squamous cell carcinoma or nearest available, but not including adenocarcinoma.
  17. e Adenocarcinoma or nearest available, but not including squamous cell carcinoma.
  18. f Or nearest available.
  19. Preference order for cigarette type – filter only/NOS, always, mainly, both, equally, ever.
  20. Preference order for comparison group – plain only/NOS, always, mainly, ever.
  21. g Or nearest available.
  22. Preference order for cigarette type – filter ever, equally, both, mainly, always, only/NOS.
  23. Preference order for comparison group – plain only/NOS, always, mainly, ever.
  24. h Or nearest available.
  25. Preference order for cigarette type – filter only/NOS, always, mainly, both, equally, ever.
  26. Preference order for comparison group – plain ever, mainly, always, only/NOS.
  27. i Preference order for cigarette type – handrolled any, both, mainly, only.
  28. Preference order for comparison group – manufactured only ever, only current, any, ever.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us